ArticleCancer management and research2025

The Combination of D-TACE-HAIC, Lenvatinib, and PD-1 Inhibitors Shows Significant Clinical Efficacy in Patients with Unresectable Hepatocellular Carcinoma.

Yintao Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.